Key Insights
The global breast biopsy market, valued at $0.41 billion in 2025, is projected to experience robust growth, driven by several key factors. The increasing incidence of breast cancer, coupled with advancements in biopsy techniques offering minimally invasive procedures and improved diagnostic accuracy, are major contributors to this expansion. Technological advancements, such as the development of image-guided biopsies (stereotactic, ultrasound, and MRI-guided), contribute to earlier and more precise detection, leading to improved patient outcomes and increased market demand. Furthermore, the rising adoption of molecular diagnostic tests performed on biopsy samples to guide treatment decisions (e.g., hormone receptor status, HER2 status) further fuels market growth. The market is segmented by circulating biomarkers (Circulating Tumor Cells, cfDNA, extracellular vesicles, others), reflecting the growing interest in liquid biopsies as less invasive alternatives to traditional tissue biopsies. Competition is fierce, with established players like Hoeffmann-La Roche and Illumina alongside emerging innovative companies offering a range of technologies and services. Geographic variations exist, with North America currently holding a significant market share due to high healthcare expenditure and technological adoption. However, developing economies in Asia-Pacific are expected to witness rapid growth due to rising awareness, improving healthcare infrastructure, and increasing affordability of advanced diagnostic procedures.
The forecast period of 2025-2033 anticipates a sustained Compound Annual Growth Rate (CAGR) of 21.23%. This growth is expected to be fueled by ongoing technological advancements in biopsy techniques (e.g., development of advanced imaging and robotic-assisted procedures), expansion of molecular diagnostic testing capabilities, and increased healthcare spending globally. The market's segmentation by region (North America, Europe, Asia Pacific, Middle East & Africa, South America) reflects diverse market dynamics and growth potential. While North America and Europe are expected to maintain leading positions due to established healthcare infrastructure and technological innovation, the Asia-Pacific region's growth trajectory suggests a significant shift in market share over the coming years. The increasing adoption of targeted therapies and personalized medicine based on biopsy results is further expected to propel the market's future expansion. Regulatory approvals of new technologies and the ongoing research and development efforts focused on improving biopsy techniques are also contributing factors to the market's positive growth outlook.

Breast Biopsy Market: A Comprehensive Report (2019-2033)
This dynamic report provides a comprehensive analysis of the Breast Biopsy Market, offering invaluable insights into market structure, trends, opportunities, and future projections from 2019 to 2033. Leveraging extensive research and data analysis, this report is an essential resource for industry stakeholders, investors, and researchers seeking a deep understanding of this rapidly evolving market. The global Breast Biopsy Market is estimated to reach xx Million by 2025 and is projected to witness significant growth during the forecast period (2025-2033), driven by technological advancements and increasing prevalence of breast cancer.
Breast Biopsy Market Market Structure & Competitive Landscape
The Breast Biopsy Market exhibits a moderately concentrated structure, with several key players vying for market share. The Herfindahl-Hirschman Index (HHI) for 2025 is estimated at xx, indicating a moderately consolidated market. Innovation is a significant driver, fueled by the ongoing development of minimally invasive techniques and advanced diagnostic tools. Regulatory frameworks, particularly those related to medical device approvals and reimbursement policies, significantly impact market dynamics. The market faces competition from alternative diagnostic methods, including imaging techniques like mammography and ultrasound. End-user segmentation primarily comprises hospitals, diagnostic centers, and private clinics. The market has witnessed a moderate level of mergers and acquisitions (M&A) activity in recent years, with xx M&A deals recorded between 2019 and 2024. This activity reflects strategic consolidation and expansion efforts by key players.
- Market Concentration: Moderately concentrated, HHI (2025): xx
- Innovation Drivers: Minimally invasive biopsies, advanced imaging techniques, molecular diagnostics.
- Regulatory Impact: Stringent regulatory approvals for medical devices and reimbursement policies significantly affect market growth.
- Product Substitutes: Mammography, ultrasound, MRI.
- End-User Segmentation: Hospitals, diagnostic centers, private clinics.
- M&A Trends: Moderate activity, xx deals between 2019 and 2024.
Breast Biopsy Market Market Trends & Opportunities
The global Breast Biopsy Market is experiencing robust growth, driven by several key factors. The market size, valued at xx Million in 2025, is projected to register a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033). This growth is fueled by increasing breast cancer incidence rates globally, rising awareness about early detection and diagnosis, technological advancements leading to less invasive procedures, and increasing adoption of advanced diagnostic techniques such as molecular testing. Consumer preferences are shifting towards minimally invasive procedures with faster turnaround times and improved patient experience. The market is witnessing intense competition, with companies investing heavily in research and development to enhance their product offerings. Market penetration rates are improving as the technology becomes more accessible and affordable.

Dominant Markets & Segments in Breast Biopsy Market
The North American region currently holds the dominant position in the Breast Biopsy Market, followed by Europe. Within the By Circulating Biomarkers segment, Circulating Cell-free DNA (cfDNA) is the fastest-growing segment due to its non-invasive nature and potential for early cancer detection.
- Key Growth Drivers in North America: Advanced healthcare infrastructure, high healthcare expenditure, high prevalence of breast cancer, strong regulatory support.
- Key Growth Drivers in Europe: Increasing adoption of advanced diagnostic techniques, government initiatives promoting early cancer detection, growing awareness about breast cancer.
- Circulating Cell-free DNA (cfDNA): Rapid growth due to minimally invasive nature and early detection capabilities.
- Circulating Tumor Cells (CTCs): Steady growth driven by advancements in CTC isolation and analysis technologies.
- Extracellular Vesicles: Emerging segment with high potential for early detection and personalized medicine.
Breast Biopsy Market Product Analysis
Technological advancements in biopsy techniques, such as image-guided biopsies and vacuum-assisted biopsies, are driving innovation. These advancements offer improved accuracy, reduced invasiveness, and faster procedure times. The market is seeing the integration of molecular diagnostics with biopsies, enabling more precise assessment of tumor characteristics and facilitating personalized treatment decisions. This enhances the diagnostic accuracy and efficiency of breast biopsies, leading to improved patient outcomes.
Key Drivers, Barriers & Challenges in Breast Biopsy Market
Key Drivers: Increasing prevalence of breast cancer, technological advancements in minimally invasive biopsy techniques, rising demand for early and accurate diagnosis, increased awareness among patients and healthcare providers.
Challenges: High cost of advanced biopsy techniques and related diagnostic tests, regulatory complexities associated with medical device approval and reimbursement, competition from alternative diagnostic methods, supply chain disruptions related to the sourcing of specialized equipment and reagents. These factors could lead to a xx% reduction in market growth by 2033 if not effectively addressed.
Growth Drivers in the Breast Biopsy Market Market
The market is primarily driven by the increasing prevalence of breast cancer and the subsequent demand for accurate and timely diagnosis. Technological innovations, such as minimally invasive biopsy techniques and molecular diagnostic tools, further contribute to growth. Favorable regulatory frameworks and reimbursement policies also play a crucial role.
Challenges Impacting Breast Biopsy Market Growth
High costs associated with advanced technologies and skilled professionals can limit accessibility. Regulatory hurdles for new device approvals and reimbursement complexities pose a challenge. Intense competition among existing and emerging players also impacts market growth.
Key Players Shaping the Breast Biopsy Market Market
- Fluxion Biosciences Inc
- Janssen Diagnostics
- Guardant Health Inc
- Bio-Rad Laboratories Inc
- Adaptive Biotechnologies
- F Hoffmann-La Roche Ltd
- Epic Sciences
- PapGene
- Qiagen
- Pathway Genomics (OME Care)
- Exosome Diagnostics Inc
- Illumina Inc
- Myriad Genetics
- Biocept Inc
- Biodesix
Significant Breast Biopsy Market Industry Milestones
- 2020, Q4: FDA approval of a new minimally invasive biopsy device.
- 2022, Q1: Launch of a novel molecular diagnostic test for breast cancer.
- 2023, Q2: Acquisition of a small diagnostic company by a major player.
- 2024, Q3: Announcement of a large-scale clinical trial for a new biopsy technique.
Future Outlook for Breast Biopsy Market Market
The Breast Biopsy Market is poised for continued expansion driven by technological advancements, rising awareness, and increasing prevalence of breast cancer. Strategic collaborations and investments in research and development will play a crucial role in shaping future growth. The integration of AI and machine learning is expected to further enhance diagnostic accuracy and efficiency. The market presents significant opportunities for companies that can offer innovative, cost-effective, and accurate biopsy solutions.
Breast Biopsy Market Segmentation
-
1. Circulating Biomarkers
- 1.1. Circulating Tumor Cells (CTCs)
- 1.2. Circulating Cell-free DNA (cfDNA)
- 1.3. Extracellular Vesicles
- 1.4. Other Circulating Biomarkers
Breast Biopsy Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Breast Biopsy Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 21.23% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Breast Cancer; Increasing Demand for Better Minimally Invasive Therapies; Technological Advancements in the Early Stage Detection of Breast Cancer
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Issues; Poor Reimbursement Policies
- 3.4. Market Trends
- 3.4.1. The Circulating Cell-free DNA (cfDNA) Segment is Expected to Hold a Major Market Share
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 5.1.1. Circulating Tumor Cells (CTCs)
- 5.1.2. Circulating Cell-free DNA (cfDNA)
- 5.1.3. Extracellular Vesicles
- 5.1.4. Other Circulating Biomarkers
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. North America
- 5.2.2. Europe
- 5.2.3. Asia Pacific
- 5.2.4. Middle East and Africa
- 5.2.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 6. North America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 6.1.1. Circulating Tumor Cells (CTCs)
- 6.1.2. Circulating Cell-free DNA (cfDNA)
- 6.1.3. Extracellular Vesicles
- 6.1.4. Other Circulating Biomarkers
- 6.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 7. Europe Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 7.1.1. Circulating Tumor Cells (CTCs)
- 7.1.2. Circulating Cell-free DNA (cfDNA)
- 7.1.3. Extracellular Vesicles
- 7.1.4. Other Circulating Biomarkers
- 7.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 8. Asia Pacific Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 8.1.1. Circulating Tumor Cells (CTCs)
- 8.1.2. Circulating Cell-free DNA (cfDNA)
- 8.1.3. Extracellular Vesicles
- 8.1.4. Other Circulating Biomarkers
- 8.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 9. Middle East and Africa Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 9.1.1. Circulating Tumor Cells (CTCs)
- 9.1.2. Circulating Cell-free DNA (cfDNA)
- 9.1.3. Extracellular Vesicles
- 9.1.4. Other Circulating Biomarkers
- 9.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 10. South America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 10.1.1. Circulating Tumor Cells (CTCs)
- 10.1.2. Circulating Cell-free DNA (cfDNA)
- 10.1.3. Extracellular Vesicles
- 10.1.4. Other Circulating Biomarkers
- 10.1. Market Analysis, Insights and Forecast - by Circulating Biomarkers
- 11. North America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Europe Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 Germany
- 12.1.2 United Kingdom
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Rest of Europe
- 13. Asia Pacific Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 Australia
- 13.1.5 South Korea
- 13.1.6 Rest of Asia Pacific
- 14. Middle East and Africa Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 GCC
- 14.1.2 South Africa
- 14.1.3 Rest of Middle East and Africa
- 15. South America Breast Biopsy Market Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Fluxion Biosciences Inc
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Janssen Diagnostics
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Guardant Health Inc
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Bio-Rad Laboratories Inc
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Adaptive Biotechnologies
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 F Hoffmann-La Roche Ltd
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Epic Sciences
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 PapGene
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Qiagen
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Pathway Genomics (OME Care)
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 Exosome Diagnostics Inc
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.12 Illumina Inc
- 16.2.12.1. Overview
- 16.2.12.2. Products
- 16.2.12.3. SWOT Analysis
- 16.2.12.4. Recent Developments
- 16.2.12.5. Financials (Based on Availability)
- 16.2.13 Myriad Genetics
- 16.2.13.1. Overview
- 16.2.13.2. Products
- 16.2.13.3. SWOT Analysis
- 16.2.13.4. Recent Developments
- 16.2.13.5. Financials (Based on Availability)
- 16.2.14 Biocept Inc
- 16.2.14.1. Overview
- 16.2.14.2. Products
- 16.2.14.3. SWOT Analysis
- 16.2.14.4. Recent Developments
- 16.2.14.5. Financials (Based on Availability)
- 16.2.15 Biodesix
- 16.2.15.1. Overview
- 16.2.15.2. Products
- 16.2.15.3. SWOT Analysis
- 16.2.15.4. Recent Developments
- 16.2.15.5. Financials (Based on Availability)
- 16.2.1 Fluxion Biosciences Inc
List of Figures
- Figure 1: Global Breast Biopsy Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Breast Biopsy Market Volume Breakdown (K Unit, %) by Region 2024 & 2032
- Figure 3: North America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 4: North America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 5: North America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: North America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 7: Europe Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 8: Europe Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 9: Europe Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: Europe Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 11: Asia Pacific Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 12: Asia Pacific Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 13: Asia Pacific Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: Asia Pacific Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 15: Middle East and Africa Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 16: Middle East and Africa Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 17: Middle East and Africa Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: Middle East and Africa Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 19: South America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 20: South America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 21: South America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: South America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 23: North America Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 24: North America Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 25: North America Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 26: North America Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 27: North America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 28: North America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 29: North America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 30: North America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 31: Europe Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 32: Europe Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 33: Europe Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 34: Europe Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 35: Europe Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 36: Europe Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 37: Europe Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 38: Europe Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 39: Asia Pacific Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 40: Asia Pacific Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 41: Asia Pacific Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 42: Asia Pacific Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 43: Asia Pacific Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 44: Asia Pacific Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 45: Asia Pacific Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 46: Asia Pacific Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 47: Middle East and Africa Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 48: Middle East and Africa Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 49: Middle East and Africa Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 50: Middle East and Africa Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 51: Middle East and Africa Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 52: Middle East and Africa Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 53: Middle East and Africa Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 54: Middle East and Africa Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
- Figure 55: South America Breast Biopsy Market Revenue (Million), by Circulating Biomarkers 2024 & 2032
- Figure 56: South America Breast Biopsy Market Volume (K Unit), by Circulating Biomarkers 2024 & 2032
- Figure 57: South America Breast Biopsy Market Revenue Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 58: South America Breast Biopsy Market Volume Share (%), by Circulating Biomarkers 2024 & 2032
- Figure 59: South America Breast Biopsy Market Revenue (Million), by Country 2024 & 2032
- Figure 60: South America Breast Biopsy Market Volume (K Unit), by Country 2024 & 2032
- Figure 61: South America Breast Biopsy Market Revenue Share (%), by Country 2024 & 2032
- Figure 62: South America Breast Biopsy Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Breast Biopsy Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Breast Biopsy Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 4: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 5: Global Breast Biopsy Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Global Breast Biopsy Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 7: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 8: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 9: United States Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: United States Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 11: Canada Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Canada Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 13: Mexico Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Mexico Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 16: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 17: Germany Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Germany Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 19: United Kingdom Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: United Kingdom Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: France Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: France Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: Italy Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Italy Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 25: Spain Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Spain Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 27: Rest of Europe Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Rest of Europe Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 29: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 30: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 31: China Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: China Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 33: Japan Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Japan Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 35: India Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: India Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 37: Australia Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Australia Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 39: South Korea Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: South Korea Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 41: Rest of Asia Pacific Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: Rest of Asia Pacific Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 43: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 44: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 45: GCC Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: GCC Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 47: South Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: South Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 49: Rest of Middle East and Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: Rest of Middle East and Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 51: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 52: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 53: Brazil Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: Brazil Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 55: Argentina Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Argentina Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 57: Rest of South America Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Rest of South America Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 59: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 60: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 61: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 62: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 63: United States Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: United States Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 65: Canada Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 66: Canada Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 67: Mexico Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 68: Mexico Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 69: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 70: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 71: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 72: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 73: Germany Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 74: Germany Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 75: United Kingdom Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 76: United Kingdom Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 77: France Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 78: France Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 79: Italy Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 80: Italy Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 81: Spain Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 82: Spain Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 83: Rest of Europe Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 84: Rest of Europe Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 85: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 86: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 87: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 88: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 89: China Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 90: China Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 91: Japan Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 92: Japan Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 93: India Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 94: India Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 95: Australia Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 96: Australia Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 97: South Korea Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 98: South Korea Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 99: Rest of Asia Pacific Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 100: Rest of Asia Pacific Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 101: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 102: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 103: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 104: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 105: GCC Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 106: GCC Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 107: South Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 108: South Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 109: Rest of Middle East and Africa Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 110: Rest of Middle East and Africa Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 111: Global Breast Biopsy Market Revenue Million Forecast, by Circulating Biomarkers 2019 & 2032
- Table 112: Global Breast Biopsy Market Volume K Unit Forecast, by Circulating Biomarkers 2019 & 2032
- Table 113: Global Breast Biopsy Market Revenue Million Forecast, by Country 2019 & 2032
- Table 114: Global Breast Biopsy Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 115: Brazil Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 116: Brazil Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 117: Argentina Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 118: Argentina Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 119: Rest of South America Breast Biopsy Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 120: Rest of South America Breast Biopsy Market Volume (K Unit) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Breast Biopsy Market?
The projected CAGR is approximately 21.23%.
2. Which companies are prominent players in the Breast Biopsy Market?
Key companies in the market include Fluxion Biosciences Inc, Janssen Diagnostics, Guardant Health Inc, Bio-Rad Laboratories Inc, Adaptive Biotechnologies, F Hoffmann-La Roche Ltd, Epic Sciences, PapGene, Qiagen, Pathway Genomics (OME Care), Exosome Diagnostics Inc, Illumina Inc, Myriad Genetics, Biocept Inc, Biodesix.
3. What are the main segments of the Breast Biopsy Market?
The market segments include Circulating Biomarkers.
4. Can you provide details about the market size?
The market size is estimated to be USD 0.41 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Breast Cancer; Increasing Demand for Better Minimally Invasive Therapies; Technological Advancements in the Early Stage Detection of Breast Cancer.
6. What are the notable trends driving market growth?
The Circulating Cell-free DNA (cfDNA) Segment is Expected to Hold a Major Market Share.
7. Are there any restraints impacting market growth?
Stringent Regulatory Issues; Poor Reimbursement Policies.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Breast Biopsy Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Breast Biopsy Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Breast Biopsy Market?
To stay informed about further developments, trends, and reports in the Breast Biopsy Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence